Overexpression of FOXO3, MYD88, and GAPDH identified by suppression subtractive hybridization in esophageal cancer is associated with autophagy

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Soltany Rezaee Rad, Mohammad ^a,b   Mottaghi Dastjerdi, Negar ^a,b   Setayesh, Neda ^a   Roshandel, Gholamreza ^c   Ebrahimifard, Farzaneh ^d   Sepehrizadeh, Zargham ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MYELOID DIFFERENTIATION FACTOR 88; TRANSCRIPTION FACTOR FKHRL1;

ARTICLE; AUTOPHAGY; CANCER CELL; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TUMOR GENE; UPREGULATION;

EID: 84893184406     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/185035     Document Type: Article

References (24)

1. Kmet J., Mahboubi E., Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 1972 175 4024 846 853 2-s2.0-0015522494
2. Bray F., Ren J.-S., Masuyer E., Ferlay J., Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International Journal of Cancer 2013 132 1133 1145
3. Anayama T., Furihata M., Takeuchi T., Sonobe H., Sasaguri S., Matsumoto M., Ohtsuki Y., Insufficient effect of p27(KIP1) to inhibit cyclin D1 in human esophageal cancer in vitro. International Journal of Oncology 2001 18 1 151 155 2-s2.0-0035233999
4. Ribeiro U., Finkelstein S. D., Safatle-Ribeiro A. V., Landreneau R. J., Clarke M. R., Bakker A., Swalsky P. A., Gooding W. E., Posner M. C., p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 1998 83 7 18 (Pubitemid 28299623)
5. Ralhan R., Arora S., Chattopadhyay T. K., Shukla N. K., Mathur M., Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India. International Journal of Cancer 2000 85 791 795 (Pubitemid 30131467)
6. Nita M. E., Nagawa H., Tominaga O., Tsuno N., Hatano K., Kitayama J., Tsuruo T., Domene C. E., Muto T., p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb. Annals of Surgical Oncology 1999 6 5 481 488 2-s2.0-0032797713 10.1007/s10434-999-0481-x (Pubitemid 29379567)
7. Maycotte P., Thorburn A., Autophagy and cancer therapy. Cancer Biology and Therapy 2011 11 2 127 137 2-s2.0-78751492210 10.4161/cbt.11.2.14627
8. Moretti L., Yang E. S., Kim K. W., Lu B., Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resistance Updates 2007 10 4-5 135 143 2-s2.0-34648823750 10.1016/j.drup.2007.05.001 (Pubitemid 47454724)
9. Chen N., Debnath J., Autophagy and tumorigenesis. FEBS Letters 2010 584 7 1427 1435 2-s2.0-77950509348 10.1016/j.febslet.2009.12.034
10. Yang L., Yu Y., Kang R., Yang M., Xie M., Wang Z., Tang D., Zhao M., Liu L., Zhang H., Cao L., Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leukemia and Lymphoma 2012 53 2 315 322 2-s2.0-84856098586 10.3109/10428194.2011.616962
11. Klionsky D. J., Emr S. D., Autophagy as a regulated pathway of cellular degradation. Science 2000 290 5497 1717 1721 2-s2.0-0034537290 10.1126/science.290.5497.1717 (Pubitemid 32004796)
12. Glick D., Barth S., Macleod K. F., Autophagy: cellular and molecular mechanisms. Journal of Pathology 2010 221 1 3 12 2-s2.0-77950994646 10.1002/path.2697
13. Kondo Y., Kanzawa T., Sawaya R., Kondo S., The role of autophagy in cancer development and response to therapy. Nature Reviews Cancer 2005 5 9 726 734 2-s2.0-25444440875 10.1038/nrc1692 (Pubitemid 41486365)
14. Kondo Y., Kondo S., Autophagy and cancer therapy. Autophagy 2006 2 2 85 90 2-s2.0-33645944960
15. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., Burden S. J., Di Lisi R., Sandri C., Zhao J., Goldberg A. L., Schiaffino S., Sandri M., FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metabolism 2007 6 6 458 471 2-s2.0-36448940798 10.1016/j.cmet.2007.11.001 (Pubitemid 350163055)
16. Zhao J., Brault J. J., Schild A., Cao P., Sandri M., Schiaffino S., Lecker S. H., Goldberg A. L., FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metabolism 2007 6 6 472 483 2-s2.0-36448968532 10.1016/j.cmet.2007.11.004 (Pubitemid 350163056)
17. Zhou J., Liao W., Yang J., Ma K., Li X., Wang Y., Wang D., Wang L., Zhang Y., Yin Y., Zhao Y., Zhu W.-G., FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway. Autophagy 2012 8 1712 1723
18. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C. A. Jr., MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Molecular Cell 1998 2 2 253 258 2-s2.0-0032133278 (Pubitemid 128373651)
19. Wang E. L., Qian Z. R., Nakasono M., Tanahashi T., Yoshimoto K., Bando Y., Kudo E., Shimada M., Sano T., High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. British Journal of Cancer 2010 102 5 908 915 2-s2.0-77649272127 10.1038/sj.bjc.6605558
20. Wang J. H., Manning B. J., Wu Q. D., Blankson S., Bouchier-Hayes D., Redmond H. P., Endotoxin/lipopolysaccharide activates NF- b and enhances tumor cell adhesion and invasion through a β 1 integrin-dependent mechanism. Journal of Immunology 2003 170 2 795 804 2-s2.0-0037438340 (Pubitemid 36070531)
21. Shi C.-S., Kehrl J. H., MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. Journal of Biological Chemistry 2008 283 48 33175 33182 2-s2.0-57749100267 10.1074/jbc.M804478200
22. Colell A., Ricci J.-E., Tait S., Milasta S., Maurer U., Bouchier-Hayes L., Fitzgerald P., Guio-Carrion A., Waterhouse N. J., Li C. W., Mari B., Barbry P., Newmeyer D. D., Beere H. M., Green D. R., GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007 129 5 983 997 2-s2.0-34249279169 10.1016/j.cell.2007.03. 045 (Pubitemid 46813151)
23. Jin S., White E., Role of autophagy in cancer: management of metabolic stress. Autophagy 2007 3 1 28 31 2-s2.0-33846244269 (Pubitemid 46100707)
24. O'Donovan T. R., O'Sullivan G. C., McKenna S. L., Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 2011 7 5 509 524 2-s2.0-79955676537 10.4161/auto.7.5.15066